BNF for Children (BNFC) 2020-2021
- Brand: Unbranded
Description
Aronson, J. K. (2004). "Drug interactions-information, education, and the British National Formulary". British Journal of Clinical Pharmacology. 57 (4): 371–372. doi: 10.1111/j.1365-2125.2004.02125.x. PMC 1884473. PMID 15025733. Specialist drug” monographs within BNF Publications: identification and reduced level of detail, see How to use BNF Publications online. COVID-19 vaccine: update to Pfizer/BioNTech vaccine ( Comirnaty®) to include use in children from 6 months old. BNF - NHS Evidence - Search Engine for Evidence in Health and Social Care". Archived from the original on 1 October 2012 . Retrieved 2012-06-14.
This update contains 4 significant changes, 1 dose change, 1 new preparation, 1 deleted monograph and 2 deleted preparations. Nitrofurantoin: reminder of the risks of pulmonary and hepatic adverse drug reactions [MHRA/CHM advice]. It is provided to NHS staff - usually through their employer, but may be accessed online through MedicinesComplete. [10]The entries are classified by group of drug, giving cautions for use, side effects, indications and dose for most of the drugs available for children in the UK National Health Service. It also includes information on the unlicensed uses of certain drugs. Though published in and for the United Kingdom, the vast bulk of the clinical information will apply in any country. Valproate: reminder of current Pregnancy Prevention Programme requirements; information on new safety measures to be introduced in the coming months [MHRA/CHM advice] (advice in sodium valproate, valproic acid; see example in sodium valproate). It was first published in 1949, [2] as the National Formulary, with updated versions appearing every three years until 1976. The fifth version in 1957 saw its name change to The British National Formulary. [4] [5] A new-look version, under the auspices of Owen Wade, was released in 1981. [2] [6] A study in Northern Ireland, looking at prescribing in 1965, reported that the BNF was likely able to serve the requirements of prescribers in general practice, while also achieving a cost saving. [7] By 2003, issue 46 of the BNF contained 3000 interactions or groups of interactions, with about 900 of these marked by a bullet. [8] [9] [10] [11] [12] [13] Editions [ edit ]
Tranexamic acid: new indications for haemorrhage following major trauma, and prevention and treatment of haemorrhage following head injury.Genital system infections, antibacterial therapy: addition of an overview section, and updated guidance for the management of syphilis. Vaccines update: restructure of monograph content—creation of two class monographs, Vaccines, general (information common to all vaccines) and Vaccines, live (information relevant to live vaccines only); see examples in yellow fever vaccine or hepatitis A vaccine. Anon (1978). "British National Formulary 1976-8". British Medical Journal. 2 (6136): 580–581. doi: 10.1136/bmj.2.6136.580-b. PMC 1606955. PMID 20792725. Drugs that cause hepatotoxicity, drugs with CNS depressant effects, and drugs that increase serum potassium: pharmacodynamic effects drug groups revalidated and updated; see Appendix 1 interactions.
Cefixime [update to include dosing in children from 12 years old for uncomplicated gonorrhoea and disseminated gonococcal infection]. NICE apps for smartphones and tablets". www.nice.org.uk. National Institute for Health and Care Excellence. April 2014. Archived from the original on 13 August 2014 . Retrieved 19 July 2014. Wade, O. L. (1993). "British National Formulary: Its birth, death, and rebirth". BMJ (Clinical Research Ed.). 306 (6884): 1051–1054. doi: 10.1136/bmj.306.6884.1051. PMC 1676980. PMID 8490505. Hyoscine hydrobromide patches (Scopoderm® 1.5 mg patch or Scopoderm® TTS patch): risk of anticholinergic side effects, including hyperthermia [MHRA/CHM advice]. Controlled drugs and drug dependence: updated guidance on prescription requirements for Schedule 2 and 3 Controlled Drugs.a b c d e "BNF Publications - Books". www.bnf.org. BMJ Group and Royal Pharmaceutical Society. Archived from the original on 17 August 2016 . Retrieved 16 August 2016.
Information on drugs is drawn from the manufacturers' product literature, medical and pharmaceutical literature, regulatory authorities and professional bodies. Advice is constructed from clinical literature, and reflects, as far as possible, an evaluation of the evidence from diverse sources. The BNF also takes account of authoritative national guidelines and emerging safety concerns. In addition, the Joint Formulary Committee takes advice on all therapeutic areas from advisers from expert groups; this ensures that the BNF's recommendations are relevant to practice. In September 2016, the National Institute for Health and Care Excellence (NICE) in the UK gave NICE accreditation to the processes to produce BNF publications; a further review in 2021 resulted in the successful renewal of accreditation. [3] History [ edit ]Anon (1957). "The British National Formulary". British Medical Journal. 2 (5047): 758–759. PMC 1962234. PMID 13460381.
- Fruugo ID: 258392218-563234582
- EAN: 764486781913
-
Sold by: Fruugo